GEODE CAPITAL MANAGEMENT, LLC - ONCOLYTICS BIOTECH INC ownership

ONCOLYTICS BIOTECH INC's ticker is ONCYF and the CUSIP is 682310107. A total of 34 filers reported holding ONCOLYTICS BIOTECH INC in Q1 2014. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ONCOLYTICS BIOTECH INC
ValueSharesWeighting
Q3 2015$20,0000.0%44,017
+3.9%
0.00%
Q2 2015$20,000
+33.3%
42,361
+96.7%
0.00%
Q1 2015$15,000
+150.0%
21,533
+81.1%
0.00%
Q4 2014$6,0000.0%11,890
+3.6%
0.00%
Q3 2014$6,000
-57.1%
11,476
+2.5%
0.00%
Q2 2014$14,000
-30.0%
11,200
-1.2%
0.00%
Q1 2014$20,000
+17.6%
11,338
+3.8%
0.00%
Q4 2013$17,000
-34.6%
10,924
+2.6%
0.00%
Q3 2013$26,000
-13.3%
10,648
+2.7%
0.00%
Q2 2013$30,00010,3720.00%
Other shareholders
ONCOLYTICS BIOTECH INC shareholders Q1 2014
NameSharesValueWeighting ↓
ACUITY INVESTMENT MANAGEMENT INC 11,157,006$27,056,0003.70%
MARXE AUSTIN W & GREENHOUSE DAVID M 731,157$1,784,0000.22%
SPROTT INC. 230,000$561,0000.06%
VSR Financial Services, Inc. 106,500$260,0000.04%
1832 Asset Management L.P. 2,684,000$6,514,0000.03%
AGF INVESTMENTS INC. 863,400$2,094,0000.02%
CANADA PENSION PLAN INVESTMENT BOARD 700,105$1,703,0000.01%
BANK OF MONTREAL /CAN/ 1,631,269$3,980,0000.01%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 50,000$122,000,0000.00%
First Eagle Investment Management, LLC 427,200$1,042,0000.00%
View complete list of ONCOLYTICS BIOTECH INC shareholders